Practice parameters for the treatment of narcolepsy: An update for 2000

Sleep

Volumn 24, Issue 4, 2001, Pages 451-466

  Littner, M ^a   Johnson, S F ^a   McCall, W V ^a   McDowell Anderson, W ^a   Davila, D ^a   Hartse, K ^a   Kushida, C A ^a   Wise, M S ^a   Hirshkowitz, M ^a   Woodson, B T ^a  

^a American Academy of Sleep Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; FLUOXETINE; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; PEMOLINE; PSYCHOSTIMULANT AGENT; SELEGILINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CHILD; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; HUMAN; NARCOLEPSY; PATIENT MONITORING; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER;

HUMANS; NARCOLEPSY;

EID: 0035877168     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Epidemiology of Narcolepsy
2. Sleep disorders in regional sleep centers: A national cooperative study
3. Narcolepsy and its treatment with stimulants. ASDA Standards of Practice
4. Practice parameters for the use of stimulants in the treatment of narcolepsy
5. Narcolepsy genes wake up the sleep field
6. Hypocretin (orexin) deficiency in human narcolepsy
7. Rules of evidence and clinical recommendation
8. Treatment of narcolepsy with methamphetamine
9. Narcolepsy
10. Amphetamine, mazindol, and fencamfamin in narcolepsy
11. The treatment of narcolepsy with methylphenylpiperidylacetate: A preliminary report
12. Treatment of narcolepsy with Ritalin
13. Treatment in the narcoleptic syndrome: Self assessment of the action of dexamphetamine and clomipramine
14. Natural history, symptoms and treatment of the narcoleptic syndrome
15. Health-related quality of life effects of modafinil for treatment of narcolepsy
16. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
17. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
18. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy
19. Modafinil: A double-blind multicentric study
20. Effects of modafinil on symptomatology of human narcolepsy
21. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil
22. Modafinil in diurnal sleepiness. A study of 123 patients
23. Use of modafinil in the treatment of narcolepsy: A long term follow-up study
24. Selegiline in the treatment of narcolepsy
25. Selegiline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study
26. Selegiline in narcolepsy
27. The treatment of accessory symptoms in narcolepsy: A double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo
28. Fluoxetine suppresses human cataplexy: A pilot study
29. HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy
30. Diagnostic aspects of narcolepsy
31. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy
32. Comparison of simulated driving performance in narcolepsy and sleep apnea patients
33. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls
34. Life effects of narcolepsy: Relationships to geographic origin (North American, Asian or European) and to other patient and illness variables
35. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: A controlled study
36. Vigilance and automobile accidents in patients with sleep apnea or narcolepsy
37. Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology
38. All-day performance variations in normal and narcoleptic subjects
39. Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy
40. The alerting effects of short and long naps in narcoleptic, sleep deprived, and alert individuals
41. The effect of regularly scheduled naps on sleep attacks and excessive daytime sleepiness associated with narcolepsy
42. Pemoline-associated hepatic failure: A critical analysis of the literature
43. Modafinil for narcolepsy
44. Effects of gestational exposure to monoamine oxidase inhibitors in rats: Preliminary behavioral and neurochemical studies
45. Compliance with stimulant medications in patients with narcolepsy
46. The clinical use of the multiple sleep latency test
47. A new method for measuring daytime sleepiness: The Epworth sleepiness scale
48. Differential effects of a new central adrenergic agonist - Modafinil - And D-amphetamine on sleep and early morning behaviour in young healthy volunteers
49. Blood pressure effects of long-term stimulant use in disorders of hypersomnolence
50. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder
51. Americans with Disabilities Act of 1990. A primer of Title I provisions for occupational health care professionals
52. Review of regulations and guidelines for commercial and noncommercial drivers with sleep apnea and narcolepsy
53. Gamma-hydroxy-butyrate in the treatment of narcolepsy: A preliminary report